Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_assertion type Assertion NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_head.
- NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_assertion description "[MET aberrations were associated with increased patient age (>70�years, p?=?0.003), male gender (p?=?0.01), increased tumour size (p?=?0.002), lymph node metastases (p?<?0.001), high-grade malignancy (p?<?0.001) and unfavourable overall survival (p?<?0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_provenance.
- NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_assertion evidence source_evidence_literature NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_provenance.
- NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_assertion SIO_000772 23242174 NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_provenance.
- NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_assertion wasDerivedFrom befree-2016 NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_provenance.
- NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_assertion wasGeneratedBy ECO_0000203 NP1036302.RA8P2q1kRSMox-VoXm6C8Nd6drvprK_aMHbfg50TGSh5g130_provenance.